Status:
COMPLETED
Gastric Lipase Enhanced Nasogastric Tube Study in Neonates
Lead Sponsor:
Imperial College London
Conditions:
Neonatal Disorder
Eligibility:
All Genders
1-3 years
Brief Summary
The newborn infants who are sick and those who are born prior to due date (preterm) are admitted to the neonatal unit. These babies are unable to feed through their mouth, so a special tube is passed ...
Detailed Description
STUDY OBJECTIVES Primary Objective: • To determine the sensitivity of the chemical (tributyrin) impregnated pH test strip in comparison to the routine pH test strip to increase the sensitivity of de...
Eligibility Criteria
Inclusion
- All infants (preterm and term) who require the insertion of nasogastric tubes for supplementary enteral feeding as part of their routine clinical management
Exclusion
- Clinically unstable, critically ill infants
- Infants undergoing palliative care
- Infants with bowel conditions such as necrotising enterocolitis, bowel obstruction
Key Trial Info
Start Date :
March 2 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 30 2021
Estimated Enrollment :
233 Patients enrolled
Trial Details
Trial ID
NCT04271995
Start Date
March 2 2020
End Date
December 30 2021
Last Update
March 1 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Imperial College Healthcare NHS Trust
London, United Kingdom